OE19

导出PDF

品系基本信息

细胞系名称

OE19

目录号

NM-YH07

品系描述

The cell line OE19, also known as JROECL19, was established in 1993 from an adenocarcinoma of gastric cardia/oesophageal gastric junction of a 72 year old male patient. 。该细胞系仅用于平台技术服务，不对外销售或转让。

品系状态

成瘤性验证完成

验证数据

I. Characterization of in vivo growth kinetics

The OE19 cells were subcutaneously inoculated into the M-NSG mice (NM-NSG-001) and huPBMC-(M-NSG) mice (NM-NSG-015).

image.png

Figure 1. Tumor growth curve of OE19 xenograft model (n=6)

image.png

Figure 2. Body weight change of OE19 xenograft model (n=6）

野生型细胞株不进行出售服务，仅作为荷瘤鼠和体内药效进行服务

你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看